[go: up one dir, main page]

WO2007066131A3 - A method of detecting skeletal muscle damage - Google Patents

A method of detecting skeletal muscle damage Download PDF

Info

Publication number
WO2007066131A3
WO2007066131A3 PCT/GB2006/004598 GB2006004598W WO2007066131A3 WO 2007066131 A3 WO2007066131 A3 WO 2007066131A3 GB 2006004598 W GB2006004598 W GB 2006004598W WO 2007066131 A3 WO2007066131 A3 WO 2007066131A3
Authority
WO
WIPO (PCT)
Prior art keywords
skeletal muscle
muscle damage
detecting skeletal
detecting
damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2006/004598
Other languages
French (fr)
Other versions
WO2007066131A2 (en
Inventor
Julie Christine Barnes
Paul Michael Bradley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioWisdom Ltd
Original Assignee
BioWisdom Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioWisdom Ltd filed Critical BioWisdom Ltd
Publication of WO2007066131A2 publication Critical patent/WO2007066131A2/en
Publication of WO2007066131A3 publication Critical patent/WO2007066131A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method of detecting skeletal muscle damage and to the use of certain proteins and fragments thereof as biological markers (commonly known as 'biomarkers') for such damage. The present invention has particular reference to the detection of muscle toxicity in mammals, particularly humans.
PCT/GB2006/004598 2005-12-08 2006-12-08 A method of detecting skeletal muscle damage Ceased WO2007066131A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0525048.5 2005-12-08
GB0525048A GB0525048D0 (en) 2005-12-08 2005-12-08 A method of detecting skeletal muscle damage

Publications (2)

Publication Number Publication Date
WO2007066131A2 WO2007066131A2 (en) 2007-06-14
WO2007066131A3 true WO2007066131A3 (en) 2007-11-01

Family

ID=35735782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/004598 Ceased WO2007066131A2 (en) 2005-12-08 2006-12-08 A method of detecting skeletal muscle damage

Country Status (2)

Country Link
GB (1) GB0525048D0 (en)
WO (1) WO2007066131A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078806A2 (en) * 2007-12-19 2009-06-25 Bror Christer Malm Skeletal muscle proteome, muscle function and physical performance
EP3546946A1 (en) * 2018-03-29 2019-10-02 Rüdiger Lange Method of diagnosing heart muscle damage
BR102021020613A2 (en) * 2021-10-14 2023-04-18 Universidade Federal Do Rio De Janeiro PROTEOMY INVESTIGATION METHOD IN SAMPLE FOR DIAGNOSIS OF RABDOMYOLYSIS AND KITS FOR PERFORMING THE SAME

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DARE THEO O ET AL: "Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: A biomarker of compound-induced skeletal muscle toxicity in the rat.", ELECTROPHORESIS, vol. 23, no. 18, September 2002 (2002-09-01), pages 3241 - 3251, XP002423409, ISSN: 0173-0835 *
LECHNER C ET AL: "ERK6, A MITOGEN-ACTIVATED PROTEIN KINASE INVOLVED IN C2C12 MYOBLASTDIFFERENTIATION", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 93, April 1996 (1996-04-01), pages 4355 - 4359, XP002053846, ISSN: 0027-8424 *
SORICHTER STEPHAN ET AL: "Skeletal troponin I as a marker of exercise-induced muscle damage", JOURNAL OF APPLIED PHYSIOLOGY, vol. 83, no. 4, 1997, pages 1076 - 1082, XP002423408, ISSN: 8750-7587 *

Also Published As

Publication number Publication date
GB0525048D0 (en) 2006-01-18
WO2007066131A2 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
WO2007086904A3 (en) Compositions for use in identification of adenoviruses
WO2006091734A3 (en) Compositions and methods for classifying biological samples
WO2005059103A3 (en) Corn plant mon88017 and compositions and methods for detection thereof
WO2004053062A3 (en) Bentgrass event asr-368 and compositions and methods for detection thereof
EP1905846A3 (en) Markers of renal transplant rejection and renal damage
WO2005107491A3 (en) Multi-lectin affinity chromatography and uses thereof
WO2007098184A3 (en) Methods and compositions for analyte detection
WO2004072235A3 (en) Cotton event mon 88913 and compositions and methods for detection thereof
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
WO2005111212A3 (en) Biological bar code
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
WO2007035864A3 (en) Electrophoresis standards, methods and kits
WO2005087793A3 (en) Immunostimulatory compositions and uses thereof
WO2005039626A3 (en) Use of hydroxylated amino acids for treating diabetes
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
WO2007117665A3 (en) Derivatization-enhanced analysis of amino acids and peptides
WO2006044378A3 (en) Rapid computational identification of targets
WO2007003670A8 (en) Fibrosis markers
WO2006113289A3 (en) Saposin d and fam3c are biomarkers for alzheimer's disease
WO2007066129A3 (en) A method of detecting skeletal muscle damage
WO2005089505A3 (en) Detection, isolation and uses of renalase (monoamine oxidase c)
WO2007066131A3 (en) A method of detecting skeletal muscle damage
WO2006034264A3 (en) Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis
AU2003240558A1 (en) Biological results evaluation method
WO2002086505A3 (en) Intracellular analysis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06820467

Country of ref document: EP

Kind code of ref document: A2